341 related articles for article (PubMed ID: 36992138)
1. Therapeutic Potential of Luteolin on Cancer.
Çetinkaya M; Baran Y
Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992138
[TBL] [Abstract][Full Text] [Related]
2. Luteolin, a Potent Anticancer Compound: From Chemistry to Cellular Interactions and Synergetic Perspectives.
Singh Tuli H; Rath P; Chauhan A; Sak K; Aggarwal D; Choudhary R; Sharma U; Vashishth K; Sharma S; Kumar M; Yadav V; Singh T; Yerer MB; Haque S
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358791
[TBL] [Abstract][Full Text] [Related]
3. Luteolin, a flavonoid with potential for cancer prevention and therapy.
Lin Y; Shi R; Wang X; Shen HM
Curr Cancer Drug Targets; 2008 Nov; 8(7):634-46. PubMed ID: 18991571
[TBL] [Abstract][Full Text] [Related]
4. Luteolin, a flavonoid, as an anticancer agent: A review.
Imran M; Rauf A; Abu-Izneid T; Nadeem M; Shariati MA; Khan IA; Imran A; Orhan IE; Rizwan M; Atif M; Gondal TA; Mubarak MS
Biomed Pharmacother; 2019 Apr; 112():108612. PubMed ID: 30798142
[TBL] [Abstract][Full Text] [Related]
5. Distribution and biological activities of the flavonoid luteolin.
López-Lázaro M
Mini Rev Med Chem; 2009 Jan; 9(1):31-59. PubMed ID: 19149659
[TBL] [Abstract][Full Text] [Related]
6. Luteolin exerts an anticancer effect on gastric cancer cells through multiple signaling pathways and regulating miRNAs.
Pu Y; Zhang T; Wang J; Mao Z; Duan B; Long Y; Xue F; Liu D; Liu S; Gao Z
J Cancer; 2018; 9(20):3669-3675. PubMed ID: 30405835
[TBL] [Abstract][Full Text] [Related]
7. Role of microRNAs in the anticancer effects of the flavonoid luteolin: a systematic review.
Mishan MA; Khazeei Tabari MA; Mahrooz A; Bagheri A
Eur J Cancer Prev; 2021 Sep; 30(5):413-421. PubMed ID: 33720053
[TBL] [Abstract][Full Text] [Related]
8. Multi-Faceted Role of Luteolin in Cancer Metastasis: EMT, Angiogenesis, ECM Degradation and Apoptosis.
Rocchetti MT; Bellanti F; Zadorozhna M; Fiocco D; Mangieri D
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240168
[TBL] [Abstract][Full Text] [Related]
9. Investigation of U-251 cell death triggered by flavonoid luteolin: towards a better understanding on its anticancer property against glioblastomas.
Franco YEM; de Lima CA; Rosa MN; Silva VAO; Reis RM; Priolli DG; Carvalho PO; do Nascimento JR; da Rocha CQ; Longato GB
Nat Prod Res; 2021 Nov; 35(22):4807-4813. PubMed ID: 32081041
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
[TBL] [Abstract][Full Text] [Related]
11. Application of Luteolin in Neoplasms and Nonneoplastic Diseases.
Rakoczy K; Kaczor J; Sołtyk A; Szymańska N; Stecko J; Sleziak J; Kulbacka J; Baczyńska D
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958980
[TBL] [Abstract][Full Text] [Related]
12. Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways.
Almatroodi SA; Alsahli MA; Almatroudi A; Verma AK; Aloliqi A; Allemailem KS; Khan AA; Rahmani AH
Molecules; 2021 Mar; 26(5):. PubMed ID: 33804548
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of metastasis suppression by luteolin in breast cancer.
Cook MT
Breast Cancer (Dove Med Press); 2018; 10():89-100. PubMed ID: 29928143
[TBL] [Abstract][Full Text] [Related]
14. Immunopharmacological Activities of Luteolin in Chronic Diseases.
Huang L; Kim MY; Cho JY
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768462
[TBL] [Abstract][Full Text] [Related]
15. The antitumor activities of flavonoids.
Kandaswami C; Lee LT; Lee PP; Hwang JJ; Ke FC; Huang YT; Lee MT
In Vivo; 2005; 19(5):895-909. PubMed ID: 16097445
[TBL] [Abstract][Full Text] [Related]
16. Advances in the Mechanism of Luteolin against Hepatocellular Carcinoma Based on Bioinformatics and Network Pharmacology.
Han Y; Xiao Y; Yu L; Chen J; Yang X; Cui H; Liang J
J Cancer; 2023; 14(6):966-980. PubMed ID: 37151401
[TBL] [Abstract][Full Text] [Related]
17. Flavonoid-Based Cancer Therapy: An Updated Review.
Hosseinzadeh E; Hassanzadeh A; Marofi F; Alivand MR; Solali S
Anticancer Agents Med Chem; 2020; 20(12):1398-1414. PubMed ID: 32324520
[TBL] [Abstract][Full Text] [Related]
18. Luteolin induces cell cycle arrest and apoptosis through extrinsic and intrinsic signaling pathways in MCF-7 breast cancer cells.
Park SH; Ham S; Kwon TH; Kim MS; Lee DH; Kang JW; Oh SR; Yoon DY
J Environ Pathol Toxicol Oncol; 2014; 33(3):219-31. PubMed ID: 25272060
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
Chakrabarti M; Ray SK
Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275
[TBL] [Abstract][Full Text] [Related]
20. Recent Updates on Source, Biosynthesis, and Therapeutic Potential of Natural Flavonoid Luteolin: A Review.
Muruganathan N; Dhanapal AR; Baskar V; Muthuramalingam P; Selvaraj D; Aara H; Shiek Abdullah MZ; Sivanesan I
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
